1. Acute lysyl oxidase inhibition alters microvascular function in normotensive but not hypertensive men and women
   Daniel H. Craighead et al, 2018, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
2. Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking
   Wenshan Zhao et al, 2018, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
3. LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry
   Nan Zhao et al, 2023, Digestive and Liver Disease CrossRef
4. LncRNA CARMN Affects Hepatocellular Carcinoma Prognosis by Regulating the miR-192-5p/LOXL2 Axis
   Xiaokang Wang et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
5. Multiple Roles of LOXL2 in the Progression of Hepatocellular Carcinoma and Its Potential for Therapeutic Targeting
   Jelena Radić et al, 2023, International Journal of Molecular Sciences CrossRef
6. Roles of Lysyl Oxidase Family Members in the Tumor Microenvironment and Progression of Liver Cancer
   Hung-Yu Lin et al, 2020, International Journal of Molecular Sciences CrossRef
7. LOXL2 Inhibitors and Breast Cancer Progression
   Sandra Ferreira et al, 2021, Antioxidants CrossRef
8. Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer
   Wei Wang et al, 2022, International Journal of Molecular Sciences CrossRef
9. Exploring breast cancer treatment paradigms: innovative design, molecular docking and dynamic simulation of LOXL2 inhibitors
   Othman A. Baothman et al, 2024, Molecular Simulation CrossRef
10. Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma
    Huajie Cai et al, 2017, Oncology Letters CrossRef
11. Prognostic utility and clinical significance of lysyl oxidase‐like 2 protein expression in digestive system cancers
    Yi Zhang et al, 2019, Journal of Cellular Physiology CrossRef
12. Inhibition of lysyl oxidase‐like 2 overcomes adhesion‐dependent drug resistance in the collagen‐enriched liver cancer microenvironment
    Lanqi Gong et al, 2022, Hepatology Communications CrossRef
13. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis
    Rongkun Li et al, 2019, Molecular Cancer CrossRef
14. Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy
    Miaomiao Ye et al, 2020, Pharmacology & Therapeutics CrossRef
15. Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis
    Fenming Zhang et al, 2016, PLOS ONE CrossRef
16. Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis
    Jiwoon Choi et al, 2019, Gut and Liver CrossRef